CELLEBRITE DI LTD (CLBT) Fundamental Analysis & Valuation

NASDAQ:CLBT • IL0011794802

Current stock price

14.84 USD
+0.26 (+1.78%)
At close:
14.84 USD
0 (0%)
Pre-Market:

This CLBT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. CLBT Profitability Analysis

1.1 Basic Checks

  • CLBT had positive earnings in the past year.
  • In the past year CLBT had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: CLBT reported negative net income in multiple years.
  • In the past 5 years CLBT always reported a positive cash flow from operatings.
CLBT Yearly Net Income VS EBIT VS OCF VS FCFCLBT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M

1.2 Ratios

  • CLBT has a better Return On Assets (8.34%) than 82.67% of its industry peers.
  • Looking at the Return On Equity, with a value of 16.17%, CLBT belongs to the top of the industry, outperforming 84.48% of the companies in the same industry.
  • With an excellent Return On Invested Capital value of 10.09%, CLBT belongs to the best of the industry, outperforming 85.56% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for CLBT is in line with the industry average of 10.87%.
Industry RankSector Rank
ROA 8.34%
ROE 16.17%
ROIC 10.09%
ROA(3y)-15.95%
ROA(5y)0.33%
ROE(3y)-101.7%
ROE(5y)N/A
ROIC(3y)10.94%
ROIC(5y)9.54%
CLBT Yearly ROA, ROE, ROICCLBT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 100 -100 -200

1.3 Margins

  • CLBT has a Profit Margin of 16.47%. This is amongst the best in the industry. CLBT outperforms 82.31% of its industry peers.
  • CLBT's Profit Margin has declined in the last couple of years.
  • With an excellent Operating Margin value of 13.98%, CLBT belongs to the best of the industry, outperforming 80.87% of the companies in the same industry.
  • In the last couple of years the Operating Margin of CLBT has grown nicely.
  • CLBT's Gross Margin of 84.20% is amongst the best of the industry. CLBT outperforms 89.89% of its industry peers.
  • In the last couple of years the Gross Margin of CLBT has remained more or less at the same level.
Industry RankSector Rank
OM 13.98%
PM (TTM) 16.47%
GM 84.2%
OM growth 3Y235.7%
OM growth 5Y24.25%
PM growth 3Y-27.32%
PM growth 5YN/A
GM growth 3Y1.2%
GM growth 5Y0.89%
CLBT Yearly Profit, Operating, Gross MarginsCLBT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. CLBT Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CLBT is creating some value.
  • CLBT has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for CLBT has been increased compared to 5 years ago.
  • There is no outstanding debt for CLBT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CLBT Yearly Shares OutstandingCLBT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
CLBT Yearly Total Debt VS Total AssetsCLBT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • CLBT has an Altman-Z score of 5.66. This indicates that CLBT is financially healthy and has little risk of bankruptcy at the moment.
  • CLBT has a better Altman-Z score (5.66) than 79.42% of its industry peers.
  • CLBT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 5.66
ROIC/WACC1.13
WACC8.89%
CLBT Yearly LT Debt VS Equity VS FCFCLBT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 1.56 indicates that CLBT should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.56, CLBT perfoms like the industry average, outperforming 46.93% of the companies in the same industry.
  • CLBT has a Quick Ratio of 1.54. This is a normal value and indicates that CLBT is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.54, CLBT perfoms like the industry average, outperforming 46.57% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.56
Quick Ratio 1.54
CLBT Yearly Current Assets VS Current LiabilitesCLBT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. CLBT Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 19.05% over the past year.
  • CLBT shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 71.00% yearly.
  • CLBT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.56%.
  • Measured over the past years, CLBT shows a quite strong growth in Revenue. The Revenue has been growing by 19.54% on average per year.
EPS 1Y (TTM)19.05%
EPS 3Y71%
EPS 5YN/A
EPS Q2Q%40%
Revenue 1Y (TTM)18.56%
Revenue growth 3Y20.67%
Revenue growth 5Y19.54%
Sales Q2Q%18.13%

3.2 Future

  • CLBT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.40% yearly.
  • Based on estimates for the next years, CLBT will show a quite strong growth in Revenue. The Revenue will grow by 16.23% on average per year.
EPS Next Y11.32%
EPS Next 2Y12.57%
EPS Next 3Y16.24%
EPS Next 5Y16.4%
Revenue Next Year19.73%
Revenue Next 2Y18.6%
Revenue Next 3Y17.73%
Revenue Next 5Y16.23%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CLBT Yearly Revenue VS EstimatesCLBT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M
CLBT Yearly EPS VS EstimatesCLBT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.2 0.4 0.6 0.8

More info and screens

Find the best growth stocksShow best growing peers

4

4. CLBT Valuation Analysis

4.1 Price/Earnings Ratio

  • CLBT is valuated quite expensively with a Price/Earnings ratio of 29.68.
  • Compared to the rest of the industry, the Price/Earnings ratio of CLBT is on the same level as its industry peers.
  • CLBT's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 25.73.
  • CLBT is valuated quite expensively with a Price/Forward Earnings ratio of 26.66.
  • The rest of the industry has a similar Price/Forward Earnings ratio as CLBT.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.72, CLBT is valued at the same level.
Industry RankSector Rank
PE 29.68
Fwd PE 26.66
CLBT Price Earnings VS Forward Price EarningsCLBT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CLBT is valued a bit cheaper than the industry average as 62.82% of the companies are valued more expensively.
  • CLBT's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CLBT is cheaper than 68.59% of the companies in the same industry.
Industry RankSector Rank
P/FCF 22.63
EV/EBITDA 36.74
CLBT Per share dataCLBT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CLBT does not grow enough to justify the current Price/Earnings ratio.
  • CLBT has a very decent profitability rating, which may justify a higher PE ratio.
  • CLBT's earnings are expected to grow with 16.24% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.62
PEG (5Y)N/A
EPS Next 2Y12.57%
EPS Next 3Y16.24%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CLBT Dividend Analysis

5.1 Amount

  • No dividends for CLBT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CLBT Fundamentals: All Metrics, Ratios and Statistics

CELLEBRITE DI LTD

NASDAQ:CLBT (3/19/2026, 8:00:01 PM)

Premarket: 14.84 0 (0%)

14.84

+0.26 (+1.78%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-11
Earnings (Next)05-12
Inst Owners49.03%
Inst Owner Change-3.9%
Ins Owners0.63%
Ins Owner ChangeN/A
Market Cap3.63B
Revenue(TTM)475.68M
Net Income(TTM)78.33M
Analysts83.08
Price Target22.44 (51.21%)
Short Float %3.92%
Short Ratio2.67
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.42%
Min EPS beat(2)1.3%
Max EPS beat(2)9.55%
EPS beat(4)4
Avg EPS beat(4)9.89%
Min EPS beat(4)1.3%
Max EPS beat(4)15.93%
EPS beat(8)8
Avg EPS beat(8)28.1%
EPS beat(12)12
Avg EPS beat(12)50.82%
EPS beat(16)13
Avg EPS beat(16)30.81%
Revenue beat(2)1
Avg Revenue beat(2)0.53%
Min Revenue beat(2)-0.21%
Max Revenue beat(2)1.27%
Revenue beat(4)1
Avg Revenue beat(4)-0.89%
Min Revenue beat(4)-3.58%
Max Revenue beat(4)1.27%
Revenue beat(8)4
Avg Revenue beat(8)0.17%
Revenue beat(12)8
Avg Revenue beat(12)1.06%
Revenue beat(16)8
Avg Revenue beat(16)-0.34%
PT rev (1m)-10.81%
PT rev (3m)-10.98%
EPS NQ rev (1m)-8.5%
EPS NQ rev (3m)-10.14%
EPS NY rev (1m)1.11%
EPS NY rev (3m)-0.22%
Revenue NQ rev (1m)-2.9%
Revenue NQ rev (3m)-2.47%
Revenue NY rev (1m)2.08%
Revenue NY rev (3m)2.53%
Valuation
Industry RankSector Rank
PE 29.68
Fwd PE 26.66
P/S 7.63
P/FCF 22.63
P/OCF 20.9
P/B 7.49
P/tB 12.81
EV/EBITDA 36.74
EPS(TTM)0.5
EY3.37%
EPS(NY)0.56
Fwd EY3.75%
FCF(TTM)0.66
FCFY4.42%
OCF(TTM)0.71
OCFY4.78%
SpS1.95
BVpS1.98
TBVpS1.16
PEG (NY)2.62
PEG (5Y)N/A
Graham Number4.72
Profitability
Industry RankSector Rank
ROA 8.34%
ROE 16.17%
ROCE 11.68%
ROIC 10.09%
ROICexc 43.46%
ROICexgc N/A
OM 13.98%
PM (TTM) 16.47%
GM 84.2%
FCFM 33.7%
ROA(3y)-15.95%
ROA(5y)0.33%
ROE(3y)-101.7%
ROE(5y)N/A
ROIC(3y)10.94%
ROIC(5y)9.54%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)12.66%
ROCE(5y)11.04%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y205.37%
ROICexc growth 5YN/A
OM growth 3Y235.7%
OM growth 5Y24.25%
PM growth 3Y-27.32%
PM growth 5YN/A
GM growth 3Y1.2%
GM growth 5Y0.89%
F-Score5
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 111.44%
Cap/Sales 2.78%
Interest Coverage 250
Cash Conversion 221.51%
Profit Quality 204.68%
Current Ratio 1.56
Quick Ratio 1.54
Altman-Z 5.66
F-Score5
WACC8.89%
ROIC/WACC1.13
Cap/Depr(3y)96.85%
Cap/Depr(5y)101.03%
Cap/Sales(3y)2.62%
Cap/Sales(5y)2.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)19.05%
EPS 3Y71%
EPS 5YN/A
EPS Q2Q%40%
EPS Next Y11.32%
EPS Next 2Y12.57%
EPS Next 3Y16.24%
EPS Next 5Y16.4%
Revenue 1Y (TTM)18.56%
Revenue growth 3Y20.67%
Revenue growth 5Y19.54%
Sales Q2Q%18.13%
Revenue Next Year19.73%
Revenue Next 2Y18.6%
Revenue Next 3Y17.73%
Revenue Next 5Y16.23%
EBIT growth 1Y16.82%
EBIT growth 3Y305.1%
EBIT growth 5Y48.52%
EBIT Next Year28.35%
EBIT Next 3Y23.3%
EBIT Next 5Y22.88%
FCF growth 1Y31.88%
FCF growth 3Y140.74%
FCF growth 5Y21.59%
OCF growth 1Y31.3%
OCF growth 3Y103.54%
OCF growth 5Y21.14%

CELLEBRITE DI LTD / CLBT Fundamental Analysis FAQ

What is the fundamental rating for CLBT stock?

ChartMill assigns a fundamental rating of 6 / 10 to CLBT.


What is the valuation status of CELLEBRITE DI LTD (CLBT) stock?

ChartMill assigns a valuation rating of 4 / 10 to CELLEBRITE DI LTD (CLBT). This can be considered as Fairly Valued.


What is the profitability of CLBT stock?

CELLEBRITE DI LTD (CLBT) has a profitability rating of 7 / 10.


How financially healthy is CELLEBRITE DI LTD?

The financial health rating of CELLEBRITE DI LTD (CLBT) is 7 / 10.


What is the expected EPS growth for CELLEBRITE DI LTD (CLBT) stock?

The Earnings per Share (EPS) of CELLEBRITE DI LTD (CLBT) is expected to grow by 11.32% in the next year.